GT
CC icon

Greenleaf Trust’s Chemours CC Stock Holding History

Greenleaf Trust’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,444
Closed -$189K – 504
2019
Q4 		$189K Buy
+10,444
New +$173K ﹤0.01% 531

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Greenleaf Trust's CC Position: Q1 2020 in Review

Greenleaf Trust sold out of Chemours (CC) in Q1 2020, closing a stake of 10,444 shares — an estimated $189K sold.

Greenleaf Trust first reported a position in CC in Q4 2019 and held it in 1 quarter. The position peaked at $189K in Q4 2019. 416 funds tracked by Wall St. Rank hold CC as of Q1 2020.

  • Greenleaf Trust reported no remaining Chemours position as of Q1 2020 after selling out during the quarter.
  • Greenleaf Trust sold 10,444 Chemours shares in Q1 2020, an estimated $189K.
  • Greenleaf Trust first reported a position in Chemours in Q4 2019 and held it in 1 quarter.
  • Greenleaf Trust's Chemours position peaked at $189K in Q4 2019.
  • 416 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Greenleaf Trust's 13F filing for Q1 2020, filed 29 Apr 2020.